Tempest Therapeutics, Inc. — Director's Dealing 2012

Oct 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2012-10-24

Reporting Person: Malley Thomas (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-24	Stock Option	$5.50	A	13098	Acquired	2022-10-23	Common Stock (13098)	Direct

Footnotes

F1: The stock option will vest in equal monthly installments at the end of each successive month following the Vesting Commencement Date through the first anniversary of the Vesting Commencement Date. For purposes of this option grant, "Vesting Commencement Date" shall mean October 24, 2012.